Health Condition 1: 7- Osteopathic
Conditions
Interventions
Intervention1: dexmedetomidine 0.5 mcg/kg
tramadol 0.5mg /kg: patient developing shivering after spinal anaesthesia intervened randomly by Dexmedetomidine -0.5 mcg/kg or Tramadol- 0.5 mg/kg , slow si
Sponsors
Dr DYPatil Hospital
Eligibility
Inclusion criteria
Inclusion criteria: >Patient giving consent >patients of either gender aged 18-65 years scheduled for elective lower abdominal, lower limb surgeries under spinal anaesthesia >American Society of Anesthesiologist physical status class I and II
Exclusion criteria
Exclusion criteria: • Patients with known hypersensitivity to dexmedetomidine or tramadol, cardio-pulmonary, renal or hepatic disease, hyperthyroidism, psychiatric disorder, urinary tract infection, severe diabetes or autonomic neuropathies, known history of substance or alcohol abuse, patients receiving any pre-medication. • cesarean section
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| cessation of shivering , Episodes of recurrenceTimepoint: shivering ceasing within 15 min after treatment , time of recurrence after treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse effects such as nausea, vomiting, bradycardia (50/min), hypotension (20% of baseline), dizziness; and sedation score will be noted. The degree of sedation will be graded on a four-point scale as Grade 1: Awake and alert, Grade 2: Drowsy, responsive to verbal stimuli, Grade 3: Drowsy, arousable to physical stimuli, Grade 4: UnarousableTimepoint: every 15 min interval hemodynemic changes | — |
Countries
India
Contacts
Public ContactDr varsha vyas
DR D Y PATIL MEDICAL COLLEGE NAVI MUMBAI
Outcome results
None listed